Related Experiment Video
Updated: Jun 25, 2026

Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
Biomedical nanotechnology using virus-based nanoparticles
G Destito1, A Schneemann, M Manchester
1Kirin Pharma USA, Inc., La Jolla, CA 92037, USA.
Abstract:
A great challenge in biomedicine is the ability to target therapeutics to specific locations in the body in order to increase therapeutic benefit and minimize adverse effects. Virus-based nanotechnology takes advantage of the natural circulatory and targeting properties of viruses, in order to design therapeutics and vaccines that specifically target tissues of interest in vivo. Cowpea mosaic virus (CPMV) and flock house virus (FHV) nanoparticle-based strategies hold great promise for the design of targeted therapeutics, as well as for structure-based vaccine approaches.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

